Page 79

Junio 2017

COMUNICACIÓN BREVE 759 Tratamiento empírico urosepsis secundaria a ureterolitiasis - M. Catalán et al 5. Dellinger R, Levy M, Rhodes A, Annane D, Gerlach H, Opal S, et al. Campaña para sobrevivir a la sepsis: recomendaciones internacionales para el tratamiento de sepsis grave y shock séptico, 2012. Crit Care Med 2013; 41. 6. Thomas M, Hooton MD. Acute complicated cystitis and pyelonephritis. Jul 2016. In: UpToDate. 7. Al Yousef SA, Younis S, Farrag E, Moussa HSh, Bayoumi FS, Ali AM. Clinical and Laboratory Profile of Urinary Tract Infections Associated with Extended Spectrum β-Lactamase Producing Escherichia coli and Klebsiella pneumoniae. Ann Clin Lab Sci 2016; 46 (4): 393-400. 8. Sweileh WM. A prospective comparative study of gentamicin and amikacin-induced nephrotoxicity in patients with normal baseline renal function. Fundamental & Clinical Pharmacology 2009; 23: 515-20. 9. Wargo KA, Edwards JD. Aminoglycoside-induced nephrotoxicity. J Pharm Pract 2014; 27: 573-7. 10. López-Novoa JM, Quiros Y, Vicente L, Morales AI, López-Hernández FJ. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 2011; 7 9 (1): 33-45. 11. Sandhu JS, Sehgal A, Gupta O, Singh A. Aminoglycoside nephrotoxicity revisited. J Indian. Acad Clin Med 2007; 8 (4): 331-3. 12. Hall KK, Lyman JA. Updated Review of Blood Culture Contamination. Clin Microbiol Rev 2006; 19 (4): 788- 802. Rev Med Chile 2017; 145: 755-759


Junio 2017
To see the actual publication please follow the link above